Erwinia asparaginase: Clinical Trials

6 trials of Erwinia asparaginase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 2 completed, 1 recruiting. 3 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Completed 1
Phase 12Active not recruiting 1, Recruiting 1
Phase 32Active not recruiting 1, Completed 1

Follow Erwinia asparaginase: new trials by email Literature Review of Erwinia asparaginase trials Research Report on Erwinia asparaginase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Venetoclax, Azacitidine, Cytarabine - Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary
Phase 1RecruitingAndrew E. Place, MD302023-03-292026-03-12
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
Venetoclax, Navitoclax, Dexamethasone - Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingSt. Jude Children's Research Hospital352022-08-252026-10-15
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
Azacitidine, Decitabine, Cytarabine - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 2Active not recruitingSt. Jude Children's Research Hospital2062017-06-152026-04-23
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Pegaspargase, Erwinia asparaginase, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric
Phase 3Active not recruitingDana-Farber Cancer Institute5602017-03-032026-07-16
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
Prednisone, Vincristine, Daunorubicin - Lymphoblastic Lymphoma
Phase 2CompletedSt. Jude Children's Research Hospital232012-05-252022-06-28
A Study of Children With Refractory or Relapsed ALL
Topotecan, dexamethasone, vincristine, E. coli Asparaginase, PEG-L-asparaginase, erwinia asparaginase - Acute Lymphoblastic Leukemia
Phase 3CompletedSt. Jude Children's Research Hospital401997-02-012008-06-04

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Myelodysplastic Syndromes (2)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neoplasm Metastasis (1)  ·  Recurrence (1)

Sponsors

St. Jude Children's Research Hospital (4)  ·  Andrew E. Place, MD (1)  ·  Dana-Farber Cancer Institute (1)

Countries

United States (6)  ·  Canada (1)

Top investigators

Andrew E Place, MD, PhD (1)  ·  Hiroto Inaba, MD,PhD (1)  ·  Melissa Burns, MD (1)  ·  Raul C. Ribiero, MD (1)  ·  Seth E. Karol, MD (1)  ·  Sima Jeha, MD (1)

Results publications

PMID 34933343, PMID 40905823, PMID 41469545